ArticleBreast cancer research and treatment2026

Integrin α2 (CD49b) blockade remodels the tumor immune microenvironment and enhances anti-PD-L1 therapy in 4T1 breast cancer model.

Ibrahim Ragab Eissa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.